US · Healthcare · Biotechnology
Analysts rate Telomir Pharmaceuticals, Inc. Common Stock a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $4.00.
| Fund | Stake |
|---|---|
| Vanguard Capital Management, LLC | 4.69% |
| Geode Capital Management, LLC | 0.99% |
| BlackRock Inc | 0.82% |
| Vanguard Fiduciary Trust Co | 0.66% |
| Northern Trust Corp | 0.18% |
| State Street Corp | 0.17% |
| Bank of New York Mellon Corp | 0.15% |
| CapTrust Financial Advisors | 0.15% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Telomir Pharmaceuticals, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.